Haematological abnormalities were more frequently reported in patients receiving PegIntron in combination with ribavirin when compared to patients receiving interferon alfa-2b in combination with ribavirin.
Hematoloogilisi kõrvalekaldeid esines sagedamini patsientidel, kes said PegIntron’ i kombinatsioonis ribaviriiniga võrreldes patsientidega, kes said interferooni alfa- 2b kombinatsioonis ribaviriiniga.